Mechanistic Insights into the Synergistic Effects of SGLT-2 Inhibitors and ACE Inhibitors/ARBs: Implications for Cardiovascular and Renal Protection in Type 2 Diabetes Mellitus and Beyond-Reference-Cited by-同舟云学术

Mechanistic Insights into the Synergistic Effects of SGLT-2 Inhibitors and ACE Inhibitors/ARBs: Implications for Cardiovascular and Renal Protection in Type 2 Diabetes Mellitus and Beyond

Published:2024-07 Issue:3 Volume:15 Page:319-320
ISSN:2543-3288
Container-title:Journal of Diabetology
language:en
Short-container-title:J Diabetol

Author:

Al Rashid Sulthan¹,Fareed Mohammad²

Affiliation:

1. Department of Pharmacology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India

2. Department of Clinical Epidemiology and Environmental Health Laboratory, Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India

Publisher

Medknow

Reference5 articles.

1. SGLT2 Inhibitors for Cardioprotection;Al Rashid;Oman Med J,2023

2. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis;Zhang;Diabetol Metab Syndr,2023

3. Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis;Woodhams;J Diabetes Complications,2023

4. Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study);Susovan;J Diabetol,2024

5. al. Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019